Reverse DCF

What growth rate is priced into Rentokil Initial plc (RKLIF)?

At the current market price of $5.93, a reverse DCF implies Rentokil Initial plc (RKLIF) must grow revenue about 12.2% per year for the next decade (22.8% in year one) to be worth what it trades for — holding margins, taxes, reinvestment, and the discount rate fixed at the model's baseline assumptions.

Market price

$5.93

Implied growth (yr 1)

22.8%

Implied 10-yr CAGR

12.2%

Run the live reverse DCF with your own assumptions →

Rentokil Initial plc (RKLIF) reverse DCF FAQ

What revenue growth rate is priced into Rentokil Initial plc (RKLIF)?

At the current market price of $5.93, a reverse DCF implies Rentokil Initial plc's revenue must grow about 12.2% per year for the next ten years (starting at 22.8% in year one) to justify the price — holding margins, taxes, reinvestment, and the discount rate at the model's baseline assumptions.

What is a reverse DCF?

A regular DCF turns growth assumptions into a fair value. A reverse DCF inverts that: it holds every other assumption fixed and solves for the single revenue-growth path that makes intrinsic value equal the current market price. The result is the growth the market is already paying for — a hurdle you can judge the business against.

How does the implied growth compare with the model's own RKLIF forecast?

The forward DCF for Rentokil Initial plc estimates a fair value of $1.09 per share, implying RKLIF is overvalued at the $5.93 market price. If the market-implied growth is well above what the forward model assumes, the price embeds more optimism than the fundamentals-anchored forecast — and vice versa.

How this RKLIF implied growth is solved

The engine takes the same 10-year DCF used for the Rentokil Initial plc fair-value estimate — margins converging to Damodaran industry benchmarks, year-by-year WACC, a reinvestment rate tied to sales-to-capital efficiency — and inverts it: instead of projecting growth to get a value, it bisects on the starting revenue-growth rate, re-running the valuation until intrinsic value matches the market price. The implied path follows the same moat-scored convergence toward the 2% terminal growth rate that the forward model uses.

The interactive version lets you change what is held fixed — margins, convergence timing, industry benchmarks — and overlays the market-implied growth path on your own editable forecast, so you can see exactly where your expectations and the market's diverge.

The implied growth re-solves when Rentokil Initial plc files a new quarterly or annual report. For educational/informational purposes only — not investment advice. Last solved 2026-08-01.